Foresite Capital Management III, LLC - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
Foresite Capital Management III, LLC ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$5,746,000
+18.6%
1,641,8040.0%15.17%
-13.7%
Q2 2022$4,843,000
-5.2%
1,641,8040.0%17.57%
+12.9%
Q1 2022$5,106,000
-8.0%
1,641,8040.0%15.56%
+10.8%
Q4 2021$5,549,000
-7.4%
1,641,8040.0%14.05%
+69.0%
Q3 2021$5,993,000
-16.3%
1,641,8040.0%8.31%
+9.5%
Q2 2021$7,158,000
-4.0%
1,641,8040.0%7.59%
+15.9%
Q1 2021$7,454,000
-20.9%
1,641,8040.0%6.54%
-40.3%
Q4 2020$9,424,000
-20.7%
1,641,8040.0%10.95%
+23.8%
Q3 2020$11,887,000
+112.9%
1,641,804
+2.6%
8.85%
+78.3%
Q2 2020$5,584,000
+89.4%
1,599,958
+6.3%
4.96%
+200.4%
Q4 2019$2,949,000
-61.8%
1,504,710
-0.2%
1.65%
-43.9%
Q3 2019$7,721,000
-32.1%
1,508,091
-5.0%
2.95%
-20.9%
Q2 2019$11,364,000
-46.1%
1,587,1010.0%3.73%
-32.1%
Q1 2019$21,077,000
+68.8%
1,587,1010.0%5.49%
+33.7%
Q4 2018$12,490,000
-27.8%
1,587,101
+1.6%
4.10%
+7.4%
Q3 2018$17,307,000
-17.4%
1,562,0400.0%3.82%
-15.4%
Q2 2018$20,963,000
+3.3%
1,562,0400.0%4.51%
+2.1%
Q1 2018$20,291,000
+267.6%
1,562,040
+160.3%
4.42%
+185.5%
Q4 2017$5,520,000
+14.1%
600,0000.0%1.55%
+16.3%
Q3 2017$4,836,000600,0001.33%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,653,495$10,367,4148.97%
Versant Venture Management, LLC 543,753$3,409,3307.06%
TCG Crossover Management, LLC 5,905,400$37,026,8586.54%
COMMODORE CAPITAL LP 5,738,500$35,9805.42%
Foresite Capital Management IV, LLC 1,787,094$11,205,0794.79%
Saturn V Capital Management LP 1,611,778$5,718,4324.74%
ACUTA CAPITAL PARTNERS, LLC 1,015,000$6,364,0503.92%
Altium Capital Management LP 1,025,000$6,426,7503.27%
Affinity Asset Advisors, LLC 1,143,531$7,169,9392.81%
GREAT POINT PARTNERS LLC 1,550,000$9,718,5001.90%
View complete list of CYMABAY THERAPEUTICS INC shareholders